Skip to content

Comstock Inc. LODE Bioleum — Revenue

Other segment segments

Corporate And Other
$4.3K-10.4%

Similar metrics at other companies

Darling Ingredients Inc. logo
DARBioenergy — Net Sales
$160.25M+18.6%
CryoPort, Inc. logo
CYRXBiologistics Solutions — Revenue
$21.67M+16.9%
MGP Ingredients logo
MGPIBiofuel and other — Sales
$66K
Pfizer logo
PFEBiopharma — Revenues:
$14.16B+5.4%
CryoPort, Inc. logo
CYRXBiostorage Bioservices — Revenue
$5.23M+20.7%
Labcorp Holdings logo
LHBiopharma Laboratory Services — Revenue
$780.6M+8.2%

Other financials

Income statement

See full
Revenue$313.5K-60.1%
Gross profit-$286.4K-184%
Operating income-$8.9M-27.1%
Net income-$9.4M-3.2%
EPS (diluted)-$3.01-450%

Balance sheet

See full
Cash & equivalents$53.0M+212%
Total debt$257.3K-98.8%
Total equity$156.4M
Total assets$218.1M+28.6%

Cash flow

See full
Operating cash flow-$5.8M-17.3%
CapEx--100%
Free cash flow-$3.5M+2.7%

Valuation

See full
Market cap$302.13M+177%
Enterprise value$249.42M+118%
P/S279.4×+247×

Profitability

See full
Gross margin-116.4%-177pp
Operating margin-3,703.7%-7,510pp
Net margin-4,010%-13,152pp
FCF margin-462.3%-171pp

Returns & leverage

See full
Return on equity-51.5%-12.9pp
Debt / equity
Current ratio4.5×+2.1×

Where this comes from

Reported directly by Comstock Inc. in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: Comstock Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Comstock Inc.'s bioleum — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Comstock Inc.'s bioleum — revenue?
Comstock Inc. (LODE) reported bioleum — revenue of $0 in Q1 2026.
What does bioleum — revenue mean?
Represents the total gross income generated from the sale of goods or services within the Bioleum business segment. This metric indicates the market adoption and commercial scale of the segment's renewable energy or resource-utilization products.